Infrastructure
Can this Company Break the Financial Barrier to Biomanufacturing?
From innovative vaccines to cell-based meats, bioproducts are a rapidly growing market. In fact, the bioproducts market will surge to $200 billion by 2040. However, according to a report from Synonym and the Boston Consulting Group, for the industry to reach this demand, biomanufacturing capacity must grow twentyfold from its current level.








